(Q54098845)

English

Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10212755

Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results. (English)

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10212755

Streptococcus pneumoniae

1 reference

based on heuristic

inferred from title

Moraxella catarrhalis

object named as

Moraxella catarrhalis

1 reference

based on heuristic

inferred from title

Haemophilus influenzae

object named as

Haemophilus influenzae

1 reference

based on heuristic

inferred from title

2

object named as

Jones RN

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10212755

author name string

Biedenbach DJ

1

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10212755

Lewis MT

3

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10212755

Croco MA

4

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10212755

Barrett MS

5

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10212755

publication date

1 April 1999

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10212755

Diagnostic Microbiology and Infectious Disease

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10212755

33

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10212755

4

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10212755

275-282

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10212755

Dirithromycin disc susceptibility tests: interpretative criteria and quality control parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900157-6

7 January 2021

based on heuristic

inferred from DOI database lookup

In-vitro activity of dirithromycin in comparison with other new and established macrolides

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900157-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Tissue distribution of dirithromycin: comparison with erythromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900157-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A five-day course of dirithromycin in the treatment of acute exacerbation of severe chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900157-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis and antimicrobial evaluation of dirithromycin (AS-E 136; LY237216), a new macrolide antibiotic derived from erythromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900157-6

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activity of dirithromycin (LY 237216) compared with activities of other macrolide antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900157-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicentre study comparing the safety and efficacy of dirithromycin with erythromycin in the treatment of bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900157-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Once-daily, 3-day azithromycin versus a three-times-daily, 10-day course of co-amoxiclav in the treatment of adults with lower respiratory tract infections: results of a randomized, double-blind comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900157-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical efficacy of dirithromycin in pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900157-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of dirithromycin on Haemophilus influenzae infection of the respiratory mucosa.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900157-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical efficacy of dirithromycin in acute exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900157-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, comparative study to evaluate the efficacy and tolerability of a 3-day course of azithromycin versus a 10-day course of co-amoxiclav as treatment of adult patients with lower respiratory tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900157-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0732-8893(98)00157-6

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10212755

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10212755

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54098845&oldid=1940488396"